Private Equity Firms in India Drive Growth in Healthcare & MedTech

Image
  India’s healthcare sector is witnessing a major transformation, fueled by increasing investments from private equity firms in India . The country, one of the fastest-growing healthcare markets in the world, is attracting substantial capital, particularly in medical technology (MedTech). In 2024, private equity investment in India saw a shift, with funding in MedTech jumping nearly fivefold to $1.2 billion, while investments in hospitals and clinics declined significantly. This shift highlights a growing emphasis on technology, innovation, and improved healthcare infrastructure. The Rise of Private Equity in Indian Healthcare Private equity (PE) and venture capital (VC) firms are showing strong confidence in private equity India , with healthcare emerging as a key sector for investment. The number of PE/VC deals in healthcare surged from 62 in 2023 to 84 in 2024, indicating rising investor interest. However, there is a noticeable change in where the money is going. While hospi...

Private Equity Firms: Changing the Landscape of Indian Healthcare Sector

The fact is, as we are living longer with an aging population, there is a growing pervasiveness of chronic diseases due to lifestyle changes and pollution; and populations are getting wealthier and want to use their disposable incomes to get access to the best treatments.

private equity firms


So long as our bodies continue to survive sickness and fail, there will always be a need to continue innovating to find better solutions. Notwithstanding economic and regulatory pressures, there is an opportunity for the industry to continue furthering revenues through the discovery of new treatments or devices that physicians and patients find valuable. Encouraged by this logic and coupled with the low-interest rates and buoyant fundraising environment, private equity firms have been drawn to healthcare.

Particularly in periods of economic inequality, investors have turned to healthcare somewhat in the same way that they have turned to precious metals or defensive industries. If one looks at the performing funds in the past few years, the best performing specialist funds were those that exclusively invested in the biotech and healthcare sector.

Healthcare deal value surged in 2020, even with valuations reaching an all-time high, some believe that we will continue at this level of M&A activity in 2021 as well. One of the reasons for the high valuation is that competition has become crowded. Healthcare private equity funds now face competition not just from strategic buyers but also new categories of players that have entered the space; these include generalist private equity investors, pension funds, sovereign wealth funds, etc. There is still scope for further private equity to penetrate the healthcare market, particularly in India where healthcare has lagged behind some other sector groups.

The dynamics are changing, and we are finding that private equity is increasingly proving that it does have the sector understanding and confidence to outbid strategic players. Funds are taking a greater risk appetite to find broader ways of deploying capital, including assets that come with high exposure to reimbursement risk.

Comments

Popular posts from this blog

Private Equity’s Role in Tackling Global Healthcare Inequalities

Quadria Capital: Powering Better Healthcare through Private Equity Investment

How Private Equity is Transforming the Healthcare Landscape in Malaysia